Abstract
Locoregional therapies, such as transarterial chemoembolization, radioembolization and thermal ablation (e.g., radiofrequency ablation) are establishing their roles in the management of liver malignancies. With yYttrium-90 radioembolization therapy (90Y) radionuclide labeled microspheres are injected into the tumor feeding artery. This allows the delivery of a high radioactive dose to the tumor with minimal toxicity to normal tissues. 90Y has demonstrated to be safe and effective in the management of liver tumors. Authors present a review of the literature available for the use of TheraSphere® for radioembolization in the management of liver tumors.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 311-316 |
| Number of pages | 6 |
| Journal | Quarterly Journal of Nuclear Medicine and Molecular Imaging |
| Volume | 53 |
| Issue number | 3 |
| State | Published - Jun 1 2009 |
Keywords
- Carcinoma, hepatocellular
- Liver neoplasms
- Operative
- Surgical procedures
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging